Finance

Roʻyxatlar
DVAI34:BVMF
Davita Inc BDR
893,56 R$
0,00%
(0,00) 1K
9-okt, 16:56:00 (GMT-3)  ·   BRL
Barcha belgilar
BelgiNarxiOʻzgartirishlarDinamika (%)
DVAI34 tikeri uchun statistika yaratilmoqda...
Ochish
893,56 R$
Yuqori
893,56 R$
Past
893,56 R$
Bozor kapitali
11,44 mlrd
Oʻrtacha hajm
7,00
Hajmi
1,00
52 haftalik eng yuqori
1 253,26 R$
52 haftalik eng past
546,63 R$
Muomaladagi aksiyalar
63,80 mln
Xodimlar soni
78 ming
Ochish
893,56 R$
Yuqori
893,56 R$
Past
893,56 R$
Bozor kapitali
11,44 mlrd
Oʻrtacha hajm
7,00
Hajmi
1,00
52 haftalik eng yuqori
1 253,26 R$
52 haftalik eng past
546,63 R$
Muomaladagi aksiyalar
63,80 mln
Xodimlar soni
78 ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Profil
DaVita Inc. is an American health care company, incorporated in Delaware and headquartered in Denver, that provides kidney dialysis services through a network of 2,657 outpatient centers in the United States. DaVita serves 200,500 patients, and has 585 outpatient centers in 14 other countries serving 94,500 patients. The company primarily treats end-stage renal disease, which requires patients to undergo kidney dialysis, often 3 times per week for the rest of their lives unless they receive a kidney transplant via organ donation. In 2025, 68% of the company's revenues came from Medicare and other government-based health insurance programs. In 2025, 89% of the company's patients were covered by government-based health insurance programs. Commercial payers, which accounted for 32% of revenues in 2025, generate nearly all of the company's profit as they reimburse at a much higher rate than government-based health insurance programs. The company is ranked 331st on the 2026 Fortune 500. Wikipedia
Davita Inc BDR haqida
CEOJavier J. Rodriguez
Xodimlar soni78 ming
Asos solingan1992
Bosh ofislarDenver, Kolorado, Amerika Qo‘shma Shtatlari
SektorHealth care provider
Veb-saytdavita.com
Avvalgi hisobotlarBarcha qiymatlar – USD
Loading Previous Earnings...
Daromad
Sof foyda
Barcha qiymatlar – USD
sen, 2025
dek, 2025
mar, 2026
iyn, 2026
Daromad
3,42 mlrd
3,62 mlrd
3,42 mlrd
3,55 mlrd
Sotilgan mahsulotning tannarxi
2,33 mlrd
2,41 mlrd
2,34 mlrd
2,39 mlrd
Daromad narxi
2,33 mlrd
2,41 mlrd
2,34 mlrd
2,39 mlrd
Tadqiqot va ishlanmalarga xarajatlar
-
-
-
-
Tadqiqot va ishlanmalarga xarajatlar jami xarajatlar
-
-
-
-
Tijoriy, umumiy va maʼmuriy xarajatlar
402,67 mln
472,36 mln
421,91 mln
423,46 mln
Operatsion xarajatlar
580,16 mln
659,06 mln
599,74 mln
591,27 mln
Jami operatsion xarajatlar
2,91 mlrd
3,07 mlrd
2,94 mlrd
2,98 mlrd
Operatsion daromad
507,30 mln
551,20 mln
473,55 mln
570,82 mln
Boshqa nooperatsion daromad
-17,26 mln
-21,03 mln
639,00 ming
4,47 mln
Soliq toʻlangunga qadar foyda, shu jumladan gʻayrioddiy moddalar
308,80 mln
382,76 mln
341,23 mln
435,01 mln
Soliq toʻlangunga qadar foyda, gʻayrioddiy moddalar bundan mustasno
351,55 mln
391,79 mln
341,23 mln
437,04 mln
Daromad soligʻi boʻyicha xarajat
68,55 mln
76,73 mln
66,20 mln
91,79 mln
Amaldagi soliq stavkasi
22,20%
20,05%
19,40%
21,10%
Boshqa operatsion xarajatlar
-
-
-
-
Sof foyda
150,33 mln
234,22 mln
197,53 mln
265,40 mln
Sof foyda marjasi
4,40%
6,47%
5,78%
7,47%
Har bir aksiya foydasi
2,51
3,40
2,87
4,02
Foizlar va investitsiyalardan olingan daromadlar
-
-
-
-
Foizlarni toʻlash xarajatlari
-148,66 mln
-148,25 mln
-141,30 mln
-146,42 mln
Foizlarni toʻlash boʻyicha sof xarajatlar
-148,66 mln
-148,25 mln
-141,30 mln
-146,42 mln
Amortizatsiya ajratmalari
177,49 mln
186,70 mln
177,83 mln
167,81 mln
EBITDA
684,80 mln
737,91 mln
651,38 mln
738,62 mln
Aktivlarni sotishdan olingan foyda yoki zarar
-
-17,55 mln
-
-
AI kontentda xatolar boʻlishi mumkin. Batafsil
Google ilovalari